Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1987 May;61(1):7–10.

Biological properties of a panel of murine monoclonal anti-Brucella antibodies.

J P Vendrell, A Delobbe, M F Huguet, F Peraldi, A Serre, A Cannat
PMCID: PMC1453296  PMID: 3583315

Abstract

Immune sera have previously been shown to play a positive role in immune protection against murine experimental brucellosis. The protective properties of a panel of five anti-Brucella monoclonal antibodies (Mabs) were therefore assessed by estimation of the acceleration of the blood clearance of intravenously inoculated Brucella and of the reduction of splenic infection on Day 7 after infection. Three 'strongly protective', one 'weakly protective' and one 'non-protective' Mabs were identified. As a first step towards the study of the mechanism of this humoral protection, these Mabs were further compared for structural and functional properties such as immunoglobulin isotype, anti-Brucella specificity, anti-Brucella in vitro bacteriostasis, Brucella agglutination and complement fixation when complexed with tyndallized Brucella. No correlation was found between protection and either agglutination or direct bacteriostasis. On the other hand, the results observed suggest that isotypes (and especially the IgG2a isotype) could play an important role in in vivo immuno protection and that complement may be involved. However, the fact that one of the protective Mabs belongs to the IgA isotype, does not cross-react with the others in anti-Brucella epitopic specificity and does not fix complement underlines the probable diversity of the mechanisms involved.

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hamilton T. A. The cell biology of macrophage activation. Annu Rev Immunol. 1984;2:283–318. doi: 10.1146/annurev.iy.02.040184.001435. [DOI] [PubMed] [Google Scholar]
  2. Alderete J. F., Kasmala L. Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis. Infect Immun. 1986 Sep;53(3):697–699. doi: 10.1128/iai.53.3.697-699.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bascoul S., Cannat A., Huguet M. F., Serre A. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum. Immunology. 1978 Aug;35(2):213–221. [PMC free article] [PubMed] [Google Scholar]
  4. Biozzi G., Stiffel C., Mouton D., Bouthillier Y., Decreusefond C. La régulation génétique de la synthìse des immunoglobulines au cours de la réponse immunologique. Ann Immunol (Paris) 1974 Jan;125C(1-2):107–142. [PubMed] [Google Scholar]
  5. Cannat A., Bousquet C., Serre A. Response of high and low antibody producer to Brucella. Ann Immunol (Paris) 1978 Jul-Sep;129 100(5):669–683. [PubMed] [Google Scholar]
  6. Ezekowitz R. A., Gordon S. Alterations of surface properties by macrophage activation: expression of receptors for Fc and mannose-terminal glycoproteins and differentiation antigens. Contemp Top Immunobiol. 1984;13:33–56. doi: 10.1007/978-1-4757-1445-6_2. [DOI] [PubMed] [Google Scholar]
  7. Griffin F. M., Jr, Griffin J. A., Silverstein S. C. Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. J Exp Med. 1976 Sep 1;144(3):788–809. doi: 10.1084/jem.144.3.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Griffin F. M., Jr, Mullinax P. J. Augmentation of macrophage complement receptor function in vitro. V. Studies on the mechanisms of ligation of macrophage Fc receptors required to trigger macrophages to signal T lymphocytes to elaborate the lymphokine that activates macrophage C3 receptors for phagocytosis. J Immunol. 1985 Jul;135(1):344–349. [PubMed] [Google Scholar]
  9. Herlyn D., Koprowski H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4761–4765. doi: 10.1073/pnas.79.15.4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Joiner K. A., Brown E. J., Frank M. M. Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol. 1984;2:461–491. doi: 10.1146/annurev.iy.02.040184.002333. [DOI] [PubMed] [Google Scholar]
  11. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  12. Lopez-Merino A., Asselineau J., Serre A., Roux J., Bascoul S., Lacave C. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances. Infect Immun. 1976 Feb;13(2):311–321. doi: 10.1128/iai.13.2.311-321.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Montaraz J. A., Winter A. J., Hunter D. M., Sowa B. A., Wu A. M., Adams L. G. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect Immun. 1986 Mar;51(3):961–963. doi: 10.1128/iai.51.3.961-963.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pardon P. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum. Ann Immunol (Paris) 1977 Nov-Dec;128(6):1025–1037. [PubMed] [Google Scholar]
  15. Plommet M., Plommet A. M. Immune serum-mediated effects on brucellosis evolution in mice. Infect Immun. 1983 Jul;41(1):97–105. doi: 10.1128/iai.41.1.97-105.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SULITZEANU D. Passive protection experiments with Brucella antisera. J Hyg (Lond) 1955 Jun;53(2):133–142. doi: 10.1017/s0022172400000619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Underdown B. J., Schiff J. M. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol. 1986;4:389–417. doi: 10.1146/annurev.iy.04.040186.002133. [DOI] [PubMed] [Google Scholar]
  18. Unkeless J. C., Fleit H., Mellman I. S. Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors. Adv Immunol. 1981;31:247–270. doi: 10.1016/s0065-2776(08)60922-0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES